Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Chi Ly"'
Autor:
John Speight, Todd Passmore, Bianca Cecconi, Placido Franco, Roberto Galimberti, Isaac Easow, Chi Ly
Publikováno v:
Proceedings of the 10th Unconventional Resources Technology Conference.
Publikováno v:
International Journal of Clinical Preventive Dentistry. 17:187-187
Autor:
Yumay Chen, Liping Yu, Charles L. Limoli, Naomi D Atkin, Ning Ru, Nathan Lee, Eric R. Siegel, Ping H. Wang, Jiao Qiao, Erich Giedzinski, Alex Gau, Khang Chi Ly, Katherine K. Tran, Francine Pan, Yi-Hong Zhou, Mark E. Linskey, Yuanjie Hu
Publikováno v:
Oncotarget, vol 8, iss 46
Oncotarget
Oncotarget
EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a937142b2f0907711b9781efde18945
https://escholarship.org/uc/item/2xf2j9b2
https://escholarship.org/uc/item/2xf2j9b2
Autor:
Vicky Kartsogiannis, Emma C. Walker, Matthew T. Gillespie, Mark J. Smyth, Morgan E. Wallace, Chi Ly, Hasnawati Saleh, Hong Zhou, Natalie A. Sims, Ingrid J Poulton, Mirijana Cipetic, T. John Martin, Kong Wah Ng, Narelle E. McGregor, J.M.W. Quinn
Publikováno v:
Journal of Biological Chemistry. 283:30850-30860
Osteoclast inhibitory lectin (OCIL or clrb) is a member of the natural killer cell C-type lectins that have a described role mostly in autoimmune cell function. OCIL was originally identified as an osteoblast-derived inhibitor of osteoclast formation
Autor:
Kong Wah Ng, S Bouralexis, Jessica L. Vieusseux, John T. Price, Chi Ly, Vicky Kartsogiannis, T. John Martin, Natalie A. Sims, Mirijana Cipetic, Matthew T. Gillespie, Akira Nakamura, Hong Zhou, Hasnawati Saleh, Julian M.W. Quinn
Publikováno v:
Bone. 40:305-315
Osteoclast inhibitory lectin (OCIL) is a type II C-type lectin and binds NK cell-associated receptor Nkrp1d and sulfated glycosaminoglycans. OCIL is expressed by several cell types found in bone and inhibits osteoclast differentiation. To determine w
Publikováno v:
Cellular Immunology. 221:64-79
Biochemical and genetic studies of thymocyte maturation would be facilitated by the development of cultured cell lines that reflect stages of positive selection. We have derived a CD4 + CD8 + TCR + T-lymphoid cell line (M20) from a murine thymic tumo
Autor:
Hong Zhou, Christine Gange, Matthew T. Gillespie, Julian M.W. Quinn, Chi Ly, J Elliott, Kong Wah Ng, Vicky Kartsogiannis
Publikováno v:
Journal of Biological Chemistry. 277:48808-48815
We have identified two novel type II membrane-bound C-lectins, designated mOCILrP1 and mOCILrP2, of 218 and 217 amino acids, respectively, that share substantial identity with the murine osteoclast inhibitory lectin (OCIL). The extracellular domains
Publikováno v:
International Journal of Prosthodontics; 2008, Vol. 21 Issue 6, p496-498, 3p
Autor:
Damian E. Myers, Matthew T. Gillespie, Vicky Kartsogiannis, William J. McKinstry, Gerald J. Atkins, Chi Ly, Andrew C.W. Zannettino, Kong Wah Ng, Yun Shan Hu, J Elliott, Christine Gange, Julian M.W. Quinn, Brett A. Cromer, Hong Zhou, Panagiota Kostakis, David M. Findlay
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 19(1)
Osteoclast inhibitory lectin (OCIL) is a newly recognized inhibitor of osteoclast formation. We identified a human homolog of OCIL and its gene, determined its regulation in human osteoblast cell lines, and established that it can inhibit murine and
Publikováno v:
Cancer research. 63(18)
Identification of signaling pathways downstream of Abl tyrosine kinase may increase our understanding of the pathogenesis of chronic myelogenous leukemia (CML) and suggest strategies to improve clinical treatment of the disease. By combining the use